99 related articles for article (PubMed ID: 11128692)
1. Pseudoporphyria induced by celecoxib in a patient with juvenile rheumatoid arthritis.
Cummins R; Wagner-Weiner L; Paller A
J Rheumatol; 2000 Dec; 27(12):2938-40. PubMed ID: 11128692
[No Abstract] [Full Text] [Related]
2. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group.
Dahlén B; Szczeklik A; Murray JJ;
N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419
[No Abstract] [Full Text] [Related]
3. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
Marks F; Harrell K; Fischer R
South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
[TBL] [Abstract][Full Text] [Related]
4. COX-2 inhibitors: new drugs for the management of pain and inflammation.
Hutchins V; Hutchins B
Dent Today; 2001 Feb; 20(2):56-61. PubMed ID: 12524847
[No Abstract] [Full Text] [Related]
5. [COX-2 specific inhibitors: are NSAIDs and the stomach become reconcilied?].
Bannwarth B
Gastroenterol Clin Biol; 2001 Apr; 25(4 Suppl):B79-84. PubMed ID: 11449148
[No Abstract] [Full Text] [Related]
6. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
Ray WA; MacDonald TM; Solomon DH; Graham DJ; Avorn J
Pharmacoepidemiol Drug Saf; 2003; 12(1):67-70. PubMed ID: 12616850
[No Abstract] [Full Text] [Related]
7. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
Wynn RL
Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
[No Abstract] [Full Text] [Related]
8. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
Palmer RH
JAMA; 2000 Apr; 283(15):1961-2. PubMed ID: 10789662
[No Abstract] [Full Text] [Related]
9. Cyclooxygenase 2 selective agents and upper gastrointestinal disease.
Fernandez H; Lesser GT
JAMA; 2000 Apr; 283(15):1961; author reply 1962. PubMed ID: 10789661
[No Abstract] [Full Text] [Related]
10. The coxibs, selective inhibitors of cyclooxygenase-2.
Killen JP
N Engl J Med; 2001 Dec; 345(23):1708; author reply 1709. PubMed ID: 11759656
[No Abstract] [Full Text] [Related]
11. [Specific inhibitors of cyclooxygenase type 2] ].
Tomasová-Studýnková J
Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
[TBL] [Abstract][Full Text] [Related]
12. COX-2 inhibitors: better than traditional NSAIDs? Vioxx and Celebrex may be no less risky than NSAIDs.
Atkinson HG
Health News; 2002 Aug; 8(8):5. PubMed ID: 12206146
[No Abstract] [Full Text] [Related]
13. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
Wright JM; Perry TL; Bassett KL; Chambers GK
JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925
[No Abstract] [Full Text] [Related]
14. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib.
Hrachovec JB; Mora M
JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924
[No Abstract] [Full Text] [Related]
15. [Selective cox-2 inhibitors. Better tolerance than NSAID plus antacid].
MMW Fortschr Med; 2004 Apr; 146(15):66. PubMed ID: 15373027
[No Abstract] [Full Text] [Related]
16. Blood pressure destabilization and edema among 8538 users of celecoxib, rofecoxib, and nonselective nonsteroidal antiinflammatory drugs (NSAID) and nonusers of NSAID receiving ordinary clinical care.
Wolfe F; Zhao S; Pettitt D
J Rheumatol; 2004 Jun; 31(6):1143-51. PubMed ID: 15170928
[TBL] [Abstract][Full Text] [Related]
17. [Adverse effect-free analgesia. New COX-2 inhibitor is even more selective].
MMW Fortschr Med; 2003 May; 145(18):54. PubMed ID: 12808824
[No Abstract] [Full Text] [Related]
18. [Current post-marketing information. Effects and adverse effects of celecoxib].
Schmidt H; Geisslinger G
Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
[No Abstract] [Full Text] [Related]
19. An update on specific COX-2 inhibitors: the COXIBs.
Gupta S; Crofford LJ
Bull Rheum Dis; 2001; 50(1):1-4. PubMed ID: 12092091
[No Abstract] [Full Text] [Related]
20. COX-2 inhibitors: no pain, no heart gain?
Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
[No Abstract] [Full Text] [Related]
[Next] [New Search]
